Last updated: 2026-10-03 04:09:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Eli Lilly & Co. (LLY) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $1,143.28, with a market capitalisation of $1.03T and a P/E ratio of 38.37. Over the past 52 weeks, its price has ranged from $783.85 to $1,292.65. This page covers its latest market performance, valuation, price trends and company information.
$1.03T | |
$1,153.82 | |
$1,292.65 | |
$27.21 | |
$1,149.85 | |
1.36M | |
2.50M | |
38.37 | |
$1,292.65 | |
$783.85 | |
0.56% | |
-- |
Eli Lilly & Co. (LLY) last closed at $1,149.85 as of 2026-10-02 23:59:16, unchanged from the previous close of $1,149.85.
During the latest regular trading session, LLY traded between $27.21 and $1,292.65, with a volume of 1.36M shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, Eli Lilly & Co. (LLY) moved from $1,150.99 to $1,143.28, representing a decline of 0.67% ($7.71).
The stock traded between $1,136.98 and $1,215.00 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 2.25 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 70.6%
LLY is currently trading at $1,143.28, placing it 70.6% of the way from its 52-week low of $783.85 to its 52-week high of $1,292.65. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 50000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Eli Lilly & Co. (LLY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.